USPTO serial 79017593
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Arzneimittel GmbH Apotheker Vetter & Co. Ravensburg
DE
Other trademarks owned by Arzneimittel GmbH Apotheker Vetter & Co. Ravensburg
Arzneimittel GmbH Apotheker Vetter & Co. Ravensburg
DE
Other trademarks owned by Arzneimittel GmbH Apotheker Vetter & Co. Ravensburg
Arzneimittel GmbH Apotheker Vetter & Co. Ravensburg
DE
Other trademarks owned by Arzneimittel GmbH Apotheker Vetter & Co. Ravensburg
| Class | Description | Status | First use |
|---|---|---|---|
| 010 | Injection syringes, injection instruments with needles, drug delivery injectors, PEN-system drug delivery injectors, auto-injectors, single-chamber and double-chamber disposable syringes; drug containers made of glass and plastic material, namely laboratory glassware; syringe holders for ready-to-use syringes for receiving and handling medical syringes; packages, containers and sets for medical and medical-technical purposes, namely packages, containers and injection sets with pre-filled ready-to-use syringes filled with inert injection solutions and saline, disposable syringes, disposable needles, ampoules, vials, swabs with or without disinfectant soaking, plasters, all in a sterile form | SECTION 71 - CANCELLED | — |
| 039 | Packaging articles for transportation, namely filling injections systems, injections syringes and instruments, injectors, PEN-system injectors and single-chamber and double-chamber disposable syringes for others with liquid, semi-solid or solid pharmaceutical products in dissolved form as active-agent solution, powder form with solvent or lyophilised with solvent; filling auto-injectors, injection syringes and injectors with sterile pharmaceutical solutions, namely injection solutions, eye drops and contact-lens solutions, for oral application in forms suitable for sale and application | SECTION 71 - CANCELLED | — |
| 042 | Chemical, physical, pharmaceutical and process-related laboratory examinations in the nature of experimental research; performance of microbiological examinations and procedures for others in the nature of experimental research | SECTION 71 - CANCELLED | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 4, 2015 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | — |
| Sep 4, 2015 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Jul 24, 2015 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Jul 7, 2015 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Jul 7, 2015 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Feb 27, 2015 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jun 27, 2014 | C71T | CANCELLED SECTION 71 | — |
| Jun 4, 2009 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 23, 2008 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 21, 2008 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Feb 20, 2008 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Feb 4, 2008 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Jan 24, 2008 | PLGL | ASSIGNED TO PARALEGAL | — |
| Dec 7, 2007 | AMD7 | SEC 7 REQUEST FILED | — |
| Dec 7, 2007 | FAXX | FAX RECEIVED | — |
| Nov 20, 2007 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 4, 2007 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 15, 2007 | NPUB | NOTICE OF PUBLICATION | — |
| Jul 30, 2007 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jul 30, 2007 | ALIE | ASSIGNED TO LIE | — |
| Jun 18, 2007 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 18, 2007 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 18, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 18, 2007 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 24, 2007 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| May 10, 2007 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 10, 2007 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Mar 9, 2007 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 9, 2007 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Feb 15, 2007 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 14, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 14, 2007 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 14, 2006 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 14, 2006 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 23, 2006 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 14, 2006 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 14, 2006 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 14, 2006 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 31, 2005 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 14, 2005 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 13, 2005 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 12, 2005 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 9, 2005 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 9, 2005 | NWAP | NEW APPLICATION ENTERED | — |
| Dec 8, 2005 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |